10-K
XBRL
FORM 10-K
- Company
- NIKA PHARMACEUTICALS, INC
- Filed
- March 24, 2021
- Period of Report
- December 31, 2020
- Accession Number
- 0001826466-21-000075
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →